Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Good, The Bad And The Correct: FDA Site Explains Ad Regs To Consumers

Executive Summary

FDA has rolled out a Web site for consumers explaining how it regulates print advertising, and plans to expand the site to include broadcast ads later this fall

You may also be interested in...



FDA’s DTC Web Site For Consumers Sparks Congressional Investigations

The pharmaceutical industry's effort to limit federal oversight of its advertising practices has become more difficult with revelations that an FDA Web site aimed at educating consumers was designed by a PR firm that has done work on drug product launches

FDA’s DTC Web Site For Consumers Sparks Congressional Investigations

The pharmaceutical industry's effort to limit federal oversight of its advertising practices has become more difficult with revelations that an FDA Web site aimed at educating consumers was designed by a PR firm that has done work on drug product launches

DoJ, Congress Want Ad Oversight: FDA Sounds Ready To Respond

The Department of Justice's level of interest in drug industry promotional issues seems to be increasing, FDA Division of Drug Marketing, Advertising & Communications Director Tom Abrams told the Food & Drug Law Institute advertising and promotion conference Sept. 8

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050134

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel